Modafinil for sleep apnea
Modafinil in untreated mild to moderate sleep apnea
We are present the results of the modafinil in mild to moderate sleep apnea trial (MOSA). Modafinil is a wakefulness promoter which has been approved for use in patients with treated sleep apnea and residual daytime sleepiness. This study provides novel data on the effect of modafinil limitless pill on daytime sleepiness in untreated sleep apnea patients, offering a potential clinical option for these patients.
We hopes to present this research at the APSS conference in Baltimore in June. The talk will be in a format of 10 min presentation + 5 minute questions/discussion. For the rest of the time, We would also like to introduce/discuss her current PhD work looking at the use of modafinil and armodafinil in patients with obstructive sleep apnea (DEAR).
- Attend a FREE Awareness Seminar on "Modafinil in untreated mild to moderate sleep apnea" Seminar at 2 PM on 2nd July,2019
- Offers and Discounts for orders.
- Online Payment option is secure.
- Delivery at the Right time.